This topic contains a solution. Click here to go to the answer

Author Question: A false negative in screening tests is the event that the test is positive for a given condition, ... (Read 92 times)

melly21297

  • Hero Member
  • *****
  • Posts: 565
A false negative in screening tests is the event that the test is positive for a given condition, given that the person does not have the condition.
  Indicate whether the statement is true or false

Question 2

Which of the following statements is false?
 a. The actual testing procedure for independence and homogeneity with contingency tables is not the same
  b. In a test of homogeneity, we are actually testing the null hypothesis: The distribution of proportions within the rows is the same for all rows.
  c. In a test of homogeneity, the alternative hypothesis is stated as: The distribution of proportions within the rows is not the same for all rows; that is, at least one is different from the others.
  d. All of the above.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lorealeza77

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

F

Answer to Question 2

A




melly21297

  • Member
  • Posts: 565
Reply 2 on: Jul 24, 2018
Wow, this really help


Sarahjh

  • Member
  • Posts: 370
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

For a complete list of videos, visit our video library